Trial Profile
A Retrospective Study Assessing The Effect of Denosumab Treatment on Trabecular Bones Score (TBS) and Lumbar Spine DXA Bone Mineral Density in Treatment Naive Patients or Patients who switched to Denosumab after Zoledronic Acid Treatment.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Jan 2018
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- 19 Jan 2018 New trial record